GDH

By Targets:	Apoptosis (5) Biochemical Assay Reagents (1) Endogenous Metabolite (7) Glutamate Dehydrogenase (GLDH) (3) Isotope-Labeled Compounds (2) PDHK (1) PKC (1) Reference Standards (2) Sirtuin (1) Small Interfering RNA (siRNA) (4) Transketolase (1)
By Research Areas:	Cancer (9) Inflammation/Immunology (6) Metabolic Disease (4)
Oligonucleotides:	Human Pre-designed siRNA Sets (4) siRNAs (4)

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-13653

(-)-Epigallocatechin Gallate Maximum Cited Publications 57 Publications Verification EGCG; Epigallocatechol Gallate	Endogenous Metabolite Apoptosis	Inflammation/Immunology Cancer
(-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

HY-103096

R162 10+ Cited Publications	Glutamate Dehydrogenase (GLDH)	Cancer
R162 is a potent inhibitor of glutamate dehydrogenase 1 (GDH1/GLUD1), with anti-cancer properties.

HY-163316

SIRT4-IN-1 2 Publications Verification	Sirtuin Glutamate Dehydrogenase (GLDH) PDHK	Metabolic Disease Cancer
SIRT4-IN-1 is a selective and potent Sirtuin 4 (Sirt4) inhibitor with an IC₅₀ of 16 μM for hSirt4. SIRT4-IN-1 also inhibits hSirt1, hSirt2, hSirt3, hSirt4 and hSirt6. SIRT4-IN-1 competes with acyl peptide substrate for Sirt4's acyl binding site, and is noncompetitive with NAD ⁺. SIRT4-IN-1 increases glutamate dehydrogenase (GDH) activity and rescues pyruvate dehydrogenase (PDH) activity. SIRT4-IN-1 inhibits adipocyte differentiation and suppresses Sirt4 overexpression-induced increased differentiation. SIRT4-IN-1 can be used for the researches of cancer and metabolic disease .

HY-13653R

(-)-Epigallocatechin Gallate (Standard) Maximum Cited Publications 57 Publications Verification EGCG(Standard); Epigallocatechol Gallate (Standard)	Reference Standards Endogenous Metabolite Apoptosis	Inflammation/Immunology Cancer
(-)-Epigallocatechin Gallate (Standard) is the analytical standard of (-)-Epigallocatechin Gallate. This product is intended for research and analytical applications. (-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

HY-N4322

Decursinol angelate 1 Publications Verification	PKC	Inflammation/Immunology Cancer
Decursinol angelate acts as a PKC activator and *GDH* inhibitor, with an IC₅₀ of 1.432 μM against human *GDH. Decursinol angelate activates PKC, downregulates PKCα* and PKCβII isoforms, and exerts cytotoxic activity against cancer cells. Decursinol angelate binds to *GDH* and inhibits its enzymatic activity. Decursinol angelate inhibits VEGF-induced autophosphorylation of VEGFR2, downstream p42/44 ERK and JNK-MAPK signaling pathways, as well as the angiogenesis process. Decursinol angelate is applicable to research related to cancer and leukemia .

HY-E70014

FAD-dependent glucose dehydrogenase FAD-GDH; Glucose 1-dehydrogenase	Endogenous Metabolite	Others
FAD-dependent glucose dehydrogenase (EC 1.1.5.9), or glucose dehydrogenase (FAD)/Pseudomonas glucose dehydrogenase. FAD-dependent glucose dehydrogenase is insensitive to O2 and displays high substrate specificity to glucose and thus is especially attractive enzymes for use in glucose biosensor applications .

HY-P3186A

NAD-dependent Glucose dehydrogenase GDH-NAD	Endogenous Metabolite	Metabolic Disease
NAD-dependent glucose dehydrogenase (GDH-NAD) is an oxidoreductase that uses NAD ⁺ as a coenzyme, specifically catalyzes the dehydrogenation of glucose to gluconolactone, and reduces NAD ⁺ to NADH. NAD-dependent glucose dehydrogenase exhibits favorable substrate selectivity and stability, and is not affected by oxygen .

HY-P3186

Glucose dehydrogenase, recombinant Microorganisms	Endogenous Metabolite	Metabolic Disease
Glucose dehydrogenase, recombinant Microorganisms is a FDA-dependent oxidoreductase. Glucose dehydrogenase (GDH) catalyzes the oxidation of β-D-glucose to β-D-glucono-1,5-lactone with simultaneous reduction of the cofactor NADP ⁺ to NADPH or, to a lesser extent, NAD ⁺ to NADH. Glucose dehydrogenase (GDH) accepts both NAD ⁺ and NADP ⁺ as cofactors and can be used for the regeneration of NADH and NADPH .

HY-E70075

α-Glycerophosphate Dehydrogenase-Triosephosphate GDH-TIM; GDH-TPI	Transketolase	Metabolic Disease
α-Glycerophosphate Dehydrogenase-Triosephosphate (GDH-TIM) is an enzyme mixture composed of glycerol phosphate dehydrogenase (GDH) and triphosphate isomerase (TIM). α-Glycerophosphate Dehydrogenase-Triosephosphate can be used to determine the activity of transketolase (TK) in hemolytic substances of red blood cells to evaluate vitamin B deficiency .

HY-150526

EGCG-4″-sulfate	Endogenous Metabolite Apoptosis	Inflammation/Immunology Cancer
EGCG-4″-sulfate is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate sulfate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. EGCG-4″-sulfate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

HY-13653S1

(-)-Epigallocatechin Gallate-d4 EGCG-d₄; Epigallocatechol Gallate-d₄	Isotope-Labeled Compounds Apoptosis	Inflammation/Immunology Cancer
(-)-Epigallocatechin Gallate-d₄ (EGCG-d₄) is the deuterium labeled (-)-Epigallocatechin Gallate (HY-13653). (-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

HY-170017S

(−)-Epigallocatechin Gallate-d3/d4 EGCG-d₃/d₄; Epigallocatechol Gallate-d₃/d₄	Isotope-Labeled Compounds Apoptosis	Inflammation/Immunology Cancer
(-)-Epigallocatechin Gallate-d₃/d₄ (EGCG-d₃/d₄) is the deuterium labeled (-)-Epigallocatechin Gallate (HY-13653). (-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

HY-RS03217

CRYL1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CRYL1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRYL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRYL1 Human Pre-designed siRNA Set A CRYL1 Human Pre-designed siRNA Set A

HY-RS05980

H6PD Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
H6PD Human Pre-designed siRNA Set A contains three designed siRNAs for H6PD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H6PD Human Pre-designed siRNA Set A H6PD Human Pre-designed siRNA Set A

HY-RS05507

GLUD1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
GLUD1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLUD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLUD1 Human Pre-designed siRNA Set A GLUD1 Human Pre-designed siRNA Set A

HY-RS15422

UGDH Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
UGDH Human Pre-designed siRNA Set A contains three designed siRNAs for UGDH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UGDH Human Pre-designed siRNA Set A UGDH Human Pre-designed siRNA Set A

HY-134136

Octanoyl Coenzyme A	Endogenous Metabolite	Others
Octanoyl coenzyme A is an enoyl-CoA hydratase binder. Octanoyl coenzyme A binds to the active site of enoyl-CoA hydratase, occupies the binding pocket for the fatty acid tail of the enzyme's substrate, and induces a conformational shift in a flexible protein loop via its longer octanoyl chain, forming an open channel leading to the inter-trimer gap .

HY-134136B

Octanoyl coenzyme A triammonium S-Octanoate-CoA triammonium; S-Octanoate-coenzyme A triammonium	Biochemical Assay Reagents	Others
Octanoyl coenzyme A triammonium is an enoyl-CoA hydratase binder. Octanoyl coenzyme A triammonium binds to the active site of enoyl-CoA hydratase, occupies the binding pocket for the fatty acid tail of the enzyme's substrate, and induces a conformational shift in a flexible protein loop via its longer octanoyl chain, forming an open channel leading to the inter-trimer gap .

HY-103096R

R162 (Standard)	Glutamate Dehydrogenase (GLDH) Reference Standards	Cancer
R162 (Standard) is the analytical standard of R162 (HY-103096). This product is intended for research and analytical applications. R162 is a potent inhibitor of glutamate dehydrogenase 1 (GDH1/GLUD1), with anti-cancer properties.

Cat. No.	Product Name

HY-L064

Glutamine Metabolism Compound Library	1,690 compounds
Glutamine is an important metabolic fuel that helps rapidly proliferating cells meet the increased demand for ATP, biosynthetic precursors, and reducing agents. Glutamine Metabolism pathway involves the initial deamination of glutamine by glutaminase(GLS), yielding glutamate and ammonia. Glutamate is converted to the TCA cycle intermediate α-ketoglutarate (α-KG) by either glutamate dehydrogenase (GDH) or by the alanine or aspartate transaminases (TAs), to produce both ATP and anabolic carbons for the synthesis of amino acids, nucleotides and lipids. During periods of hypoxia or mitochondrial dysfunction, α-KG can be converted to citrate in a reductive carboxylation reaction catalyzed by IDH2. The newly formed citrate exits the mitochondria where it is used to synthesize fatty acids and amino acids and produce the reducing agent, NADPH. Cancer cells display an altered metabolic circuitry that is directly regulated by oncogenic mutations and loss of tumor suppressors. Mounting evidence indicates that altered glutamine metabolism in cancer cells has critical roles in supporting macromolecule biosynthesis, regulating signaling pathways, and maintaining redox homeostasis, all of which contribute to cancer cell proliferation and survival. Thus, intervention in glutamine metabolic processes could provide novel approaches to improve cancer treatment. MCE owns a unique collection of 1,690 compounds targeting the mainly proteins and enzymes involved in glutamine metabolism pathway. Glutamine Metabolism compound library is a useful tool for intervention in glutamine metabolic processes.

Glutamine Metabolism Compound Library

1,690 compounds

Glutamine is an important metabolic fuel that helps rapidly proliferating cells meet the increased demand for ATP, biosynthetic precursors, and reducing agents. Glutamine Metabolism pathway involves the initial deamination of glutamine by glutaminase(GLS), yielding glutamate and ammonia. Glutamate is converted to the TCA cycle intermediate α-ketoglutarate (α-KG) by either glutamate dehydrogenase (GDH) or by the alanine or aspartate transaminases (TAs), to produce both ATP and anabolic carbons for the synthesis of amino acids, nucleotides and lipids. During periods of hypoxia or mitochondrial dysfunction, α-KG can be converted to citrate in a reductive carboxylation reaction catalyzed by IDH2. The newly formed citrate exits the mitochondria where it is used to synthesize fatty acids and amino acids and produce the reducing agent, NADPH.

Cancer cells display an altered metabolic circuitry that is directly regulated by oncogenic mutations and loss of tumor suppressors. Mounting evidence indicates that altered glutamine metabolism in cancer cells has critical roles in supporting macromolecule biosynthesis, regulating signaling pathways, and maintaining redox homeostasis, all of which contribute to cancer cell proliferation and survival. Thus, intervention in glutamine metabolic processes could provide novel approaches to improve cancer treatment.

MCE owns a unique collection of 1,690 compounds targeting the mainly proteins and enzymes involved in glutamine metabolism pathway. Glutamine Metabolism compound library is a useful tool for intervention in glutamine metabolic processes.

Cat. No.	Product Name	Type

HY-134136

Octanoyl Coenzyme A	Biochemical Assay Reagents
Octanoyl coenzyme A is an enoyl-CoA hydratase binder. Octanoyl coenzyme A binds to the active site of enoyl-CoA hydratase, occupies the binding pocket for the fatty acid tail of the enzyme's substrate, and induces a conformational shift in a flexible protein loop via its longer octanoyl chain, forming an open channel leading to the inter-trimer gap .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-13653

(-)-Epigallocatechin Gallate Maximum Cited Publications 57 Publications Verification EGCG; Epigallocatechol Gallate	Structural Classification Classification of Application Fields Anti-aging Plants Endogenous metabolite Flavonoids other families Flavonones Phenols Polyphenols Inflammation/Immunology Disease Research Fields Source Classification Cancer	Endogenous Metabolite Apoptosis
(-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

HY-13653R

(-)-Epigallocatechin Gallate (Standard) Maximum Cited Publications 57 Publications Verification EGCG(Standard); Epigallocatechol Gallate (Standard)	Flavonoids other families Classification of Application Fields Anti-aging Phenols Plants Endogenous metabolite Inflammation/Immunology Disease Research Fields Source Classification Cancer	Reference Standards Endogenous Metabolite Apoptosis
(-)-Epigallocatechin Gallate (Standard) is the analytical standard of (-)-Epigallocatechin Gallate. This product is intended for research and analytical applications. (-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

HY-N4322

Decursinol angelate 1 Publications Verification	Structural Classification Pseudognaphalium affine (D. Don) Anderberg Classification of Application Fields Coumarins Phenylpropanoids Umbelliferae Plants Inflammation/Immunology Disease Research Fields Source Classification Cancer	PKC
Decursinol angelate acts as a PKC activator and *GDH* inhibitor, with an IC₅₀ of 1.432 μM against human *GDH. Decursinol angelate activates PKC, downregulates PKCα* and PKCβII isoforms, and exerts cytotoxic activity against cancer cells. Decursinol angelate binds to *GDH* and inhibits its enzymatic activity. Decursinol angelate inhibits VEGF-induced autophosphorylation of VEGFR2, downstream p42/44 ERK and JNK-MAPK signaling pathways, as well as the angiogenesis process. Decursinol angelate is applicable to research related to cancer and leukemia .

HY-150526

EGCG-4″-sulfate	Flavonoids Classification of Application Fields Flavanols Endogenous metabolite Inflammation/Immunology Disease Research Fields Source Classification Cancer	Endogenous Metabolite Apoptosis
EGCG-4″-sulfate is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate sulfate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. EGCG-4″-sulfate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

Species:	Human (2)
Tag:	His (2) Strep (1) Tag Free (2)
Source:	E. coli (4)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P701895

	gdh2 Protein, Saccharolobus solfataricus GDH2; Glucose 1-dehydrogenase 2; GDH 2; GlcDH 2	Others	E. coli
	gdh2 protein acts as a catalyst in the NAD(P)(+)-dependent oxidation of D-glucose to D-gluconate through gluconolactone. Demonstrating versatility, it can utilize both NAD(+) and NADP(+) as electron acceptors. gdh2 plays a pivotal role in the degradation of glucose, specifically through a non-phosphorylative variant of the Entner-Doudoroff pathway. gdh2 Protein, Saccharolobus solfataricus is the recombinant gdh2 protein, expressed by E. coli , with tag free.

HY-P701896

	gdh2 Protein, Saccharolobus solfataricus (His, StrepⅡ) GDH2; Glucose 1-dehydrogenase 2; GDH 2; GlcDH 2	Others	E. coli
	gdh2 protein acts as a catalyst in the NAD(P)(+)-dependent oxidation of D-glucose to D-gluconate through gluconolactone. Demonstrating versatility, it can utilize both NAD(+) and NADP(+) as electron acceptors. gdh2 plays a pivotal role in the degradation of glucose, specifically through a non-phosphorylative variant of the Entner-Doudoroff pathway. gdh2 Protein, Saccharolobus solfataricus (His, Strep) is the recombinant gdh2 protein, expressed by E. coli , with N-Strep, N-6*His labeled tag.

HY-P701914

	GLUD1 Protein, Human GLUD1; Glutamate dehydrogenase 1; mitochondrial; GDH 1	Human	E. coli
	GLUD1 protein is a mitochondrial glutamate dehydrogenase that converts L-glutamate into α-ketoglutarate, supporting glutamine anaplerosis and the tricarboxylic acid cycle. In addition to metabolism, GLUD1 plays a key role in insulin homeostasis, complexly regulating glucose metabolism. GLUD1 Protein, Human is the recombinant human-derived GLUD1 protein, expressed by E. coli , with tag free.

HY-P701915

	GLUD1 Protein, Human (His) GLUD1; Glutamate dehydrogenase 1; mitochondrial; GDH 1	Human	E. coli
	GLUD1 protein is a mitochondrial glutamate dehydrogenase that converts L-glutamate into α-ketoglutarate, supporting glutamine anaplerosis and the tricarboxylic acid cycle. In addition to metabolism, GLUD1 plays a key role in insulin homeostasis, complexly regulating glucose metabolism. GLUD1 Protein, Human (His) is the recombinant human-derived GLUD1 protein, expressed by E. coli , with N-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-13653S1

(-)-Epigallocatechin Gallate-d4
(-)-Epigallocatechin Gallate-d₄ (EGCG-d₄) is the deuterium labeled (-)-Epigallocatechin Gallate (HY-13653). (-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

(-)-Epigallocatechin Gallate-d4

(-)-Epigallocatechin Gallate-d₄ (EGCG-d₄) is the deuterium labeled (-)-Epigallocatechin Gallate (HY-13653). (-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

HY-170017S

(−)-Epigallocatechin Gallate-d3/d4
(-)-Epigallocatechin Gallate-d₃/d₄ (EGCG-d₃/d₄) is the deuterium labeled (-)-Epigallocatechin Gallate (HY-13653). (-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

(−)-Epigallocatechin Gallate-d3/d4

(-)-Epigallocatechin Gallate-d₃/d₄ (EGCG-d₃/d₄) is the deuterium labeled (-)-Epigallocatechin Gallate (HY-13653). (-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma .

Host:	Mouse (2) Rabbit (3)
Reactivity:	Human (5) Rat (3) Mouse (3)
Application:	IHC-P (3) ICC/IF (3) IP (2) WB (5) FC (3)
Isotype:	IgG (3) IgG2b (2)
Conjugation:	Non-conjugated (5)
Clonality:	Monoclonal (3) Recombinant (2)
Modification:	Unmodified (3)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P83281

	Glutamate Dehydrogenase 1 Antibody (YA3026) GDH; GDH-X; GDH1; GLUD; Glud1; Glud1a; Glud1b; Gludl; MRG-2	WB, IHC-P, ICC/IF, FC	Human, Mouse, Rat
	Glutamate Dehydrogenase 1 Antibody (YA3026) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Glutamate Dehydrogenase 1.

HY-P83213

	GPD2 Antibody (YA2958) 1 Publications Verification GDH2; GPDM; mGPDH	WB, IP	Human, Mouse, Rat
	GPD2 Antibody (YA2958) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to GPD2.

HY-P83213A

	GPD2 Antibody (YA2958)(PBS only) GDH2; GPDM; mGPDH	WB, IP	Human, Mouse, Rat
	GPD2 Antibody (YA2958) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to GPD2.

HY-P88161

	H6PD Antibody (YA7845) CORTRD1; G6PDH; GDH	WB, IHC-P, ICC/IF, FC	Human
	H6PD Antibody (YA7845) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to H6PD.

HY-P88161A

	H6PD Antibody (YA7845)(PBS only) CORTRD1; G6PDH; GDH	WB, IHC-P, ICC/IF, FC	Human
	H6PD Antibody (YA7845) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to H6PD.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-RS03217

CRYL1 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
CRYL1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRYL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS05980

H6PD Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
H6PD Human Pre-designed siRNA Set A contains three designed siRNAs for H6PD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS05507

GLUD1 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
GLUD1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLUD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS15422

UGDH Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
UGDH Human Pre-designed siRNA Set A contains three designed siRNAs for UGDH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides